Perinatal Opioid Use

Medical University of South Carolina (MUSC)

Status: Completed

Conditions: Opioid Use; Pregnancy

Treatments: Behavioral: Perinatal OUD Treatment via Telemedicine; Behavioral: In-Person Perinatal OUD Treatment

Study type: Observational

Funder types: Other

Identifiers

NCT04049032

Pro00074655

Details and patient eligibility

About

To compare maternal and newborn outcomes among pregnant women with OUD receiving care via telemedicine versus in-person.

Full description

Participants: Pregnant women with OUD.

Intervention: Participants were seen weekly for four weeks, every two weeks for four weeks and monthly thereafter and provided relapse-prevention therapy and buprenorphine.

Design: A cohort derived from a prospectively collected database including 98 women receiving perinatal OUD treatment in an obstetric practice by telemedicine or in-person and followed until 6-8 weeks postpartum from September, 2017 to December, 2018. Logistic regression with propensity score adjustment was applied to reduce group selection bias and control for potentially confounding variables.

Setting: Four outpatient obstetric practices in the southeast.

Enrollment: 98 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult females, any race or ethnicity, age 18-45 years
• Currently pregnant
• Opioid Use Disorder (OUD)
• received in person or telemedicine treatment for OUD in their obstetrician's office

Exclusion criteria

• Not currently pregnant or receiving perinatal care
• Not in agreement with Patient-Physician Agreement

Trial design

98 participants in 2 patient groups

In-Person Participants

Description:

This group received perinatal OUD treatment in-person.

Treatment:

Behavioral: In-Person Perinatal OUD Treatment

Telemedicine Participants

Description:

This group received perinatal OUD treatment via telemedicine.

Treatment:

Behavioral: Perinatal OUD Treatment via Telemedicine